SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-247764
Filing Date
2021-08-16
Accepted
2021-08-16 16:20:23
Documents
12
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d199993d10q.htm 10-Q 1275472
2 EX-3.1 d199993dex31.htm EX-3.1 744964
3 EX-31.1 d199993dex311.htm EX-31.1 10587
4 EX-31.2 d199993dex312.htm EX-31.2 10899
5 EX-32.1 d199993dex321.htm EX-32.1 4736
6 EX-32.2 d199993dex322.htm EX-32.2 4737
7 GRAPHIC g199993dsp.jpg GRAPHIC 8653
8 GRAPHIC g199993dsp01.jpg GRAPHIC 8526
9 GRAPHIC g199993dsp1.jpg GRAPHIC 15486
10 GRAPHIC g199993dsp34.jpg GRAPHIC 8279
11 GRAPHIC g199993dsp35.jpg GRAPHIC 3790
12 GRAPHIC g199993g0809233221818.jpg GRAPHIC 61977
  Complete submission text file 0001193125-21-247764.txt   2200274
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40493 | Film No.: 211178546
SIC: 2834 Pharmaceutical Preparations